Items where Author is "Abdelmasseh, M."

(2026) Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023. JAMA. pp. 673-698. ISSN 1538-3598 (Electronic) 0098-7484 (Print) 0098-7484 (Linking)

(2026) Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990-2023: a Global Burden of Disease Study. Nature Medicine. pp. 527-544. ISSN 1078-8956

(2025) Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1873-1922. ISSN 0140-6736

(2025) Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nature Communications. p. 36.

(2025) Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1811-1872. ISSN 0140-6736

(2024) Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2204-2256. ISSN 0140-6736

(2024) Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 1989-2056. ISSN 0140-6736

(2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2100-2132. ISSN 0140-6736

(2024) Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020. Eye. pp. 2083-2101. ISSN 0950-222X

(2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2133-2161. ISSN 0140-6736

(2024) Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurology. pp. 344-381. ISSN 1474-4422

(2024) Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology. pp. 973-1003. ISSN 14744422 (ISSN)

(2024) Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet. pp. 1955-1988. ISSN 0140-6736

(2024) National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050. The Lancet. pp. 2278-2298. ISSN 01406736 (ISSN)

(2024) Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021. Lancet Gastroenterology & Hepatology. pp. 825-858.

(2024) The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2314-2340. ISSN 01406736 (ISSN)

(2023) Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. Eclinicalmedicine. p. 22.

(2023) Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026. Lancet Global Health. E385-E413. ISSN 2214-109X

(2023) Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy: European Journal of Allergy and Clinical Immunology. pp. 2232-2254. ISSN 01054538 (ISSN)

(2023) Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. Eclinicalmedicine. p. 23.

(2022) Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. Lancet Public Health. E657-E669. ISSN 2468-2667

(2022) Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infectious Diseases. pp. 1626-1647. ISSN 1473-3099

(2022) The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. LANCET ONCOLOGY. pp. 27-52. ISSN 1470-2045 1474-5488 J9 - LANCET ONCOL

(2022) The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 563-591. ISSN 0140-6736

(2021) Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050. LANCET. pp. 1317-1343. ISSN 0140-6736 1474-547X J9 - LANCET